Click on headlines below to download research

Market sentiment weighing on portfolio value
Deutsche Beteiligungs | 15/02/2019

Deutsche Beteiligungs (DBAG) is making steady progress on its investment agenda, with three new acquisitions and several follow-on funding rounds totalling…

Awaiting an earnings inflection point
UmweltBank | 14/02/2019

UmweltBank’s (UBK’s) preliminary FY18 numbers confirm the continuation of healthy lending business and deposit base growth, but also further…

Mixed media
Edel | 07/02/2019

Edel’s FY18 results showed a 6% sales increase and 7% improvement in EBITDA as it benefited from continued demand for vinyl and subsidiary Kontor…

Significant operational improvements in H2
SNP Schneider-Neureither & Partner | 07/02/2019

The primary focus in FY18 was on integrating the recent acquisitions and positioning the business for growth in anticipation of the emerging digitisation…

Growth continues apace
DATAGROUP | 05/02/2019

DATAGROUP recorded another strong year of growth with revenue increasing by 22%, including 3.3% organic growth, or 6% when adjusting for discontinued activities…

Underlying positive trends
Beta Systems | 31/01/2019

While FY18 numbers dipped as management expected, revenue and EBITDA were in the top half of guidance. The results reflected weaker software licence renewals,…

Domatinostat programme to deliver Phase II data
4SC | 31/01/2019

4SC has reported progress with both its clinical-stage assets – resminostat, a broad spectrum HDAC inhibitor, and domatinostat, a specific Class…

Capital base is boosted
SNP Schneider-Neureither & Partner | 07/01/2019

In December, SNP completed its capital increase, raising gross proceeds of €18.7m (c €17.6m net). The funds will provide the group with significant…

Retaining lefitolimod’s value
Mologen | 04/01/2019

Mologen has announced that it has terminated negotiations with Oncologie and will retain rights to lefitolimod. With the lefitolimod IMPALA Phase III readout…

Promising dendritic cell data in AML
Medigene | 04/01/2019

Medigene has reported top-line interim data from its Phase I/II clinical trial testing its dendritic cell (DC) vaccine in acute myeloid leukaemia (AML)…

Executive interview – mVise
Executive interview – mVise | 10/12/2018

In this interview mVise CEO, Manfred Götz, introduces the group's business of providing mobile services and solutions. He discusses mVises's new business…

Executive interview – Paion
Executive interview – Paion | 10/12/2018

CEO Dr Wolfgang Söhngen provides an overview of Paion’s core technology, Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anaesthetic.…

Executive interview – MyBucks
Executive interview – MyBucks | 10/12/2018

In the interview, Dave van Niekerk (Executive Chairman of MyBucks), explains the company’s business model as well as its regional and global expansion…

Executive interview – EQS Group
Executive interview – EQS Group | 10/12/2018

Achim Weick, CEO, talks through the developing market for corporate governance, risk and compliance and how EQS’s tools help companies to fulfil…

Executive Interview – Mutares
Executive Interview – Mutares | 10/12/2018

In the interview, Mark Friedrich (the company’s CFO) explains Mutares’s distinct investment approach focused on turnaround situations and the…

Executive interview – 2G Energy
Executive interview – 2G Energy | 10/12/2018

2G Energy is a leading international manufacturer of highly efficient combined heat and power (CHP) plants. These are deployed in the housing industry,…

Building future potential
Deutsche Beteiligungs | 07/12/2018

Deutsche Beteiligungs (DBAG) reported FY18 net income of €33.6m, at the top of management’s guidance range, with a 7.8% dividend-adjusted NAV…

Banking JV is abandoned with positive effect
FinTech Group | 07/12/2018

FinTech Group’s (FTG’s) proposed banking joint venture (JV) with Austrian Post has been abandoned in accordance with the feedback of the relevant…

Executive Interview - Nanogate
Executive Interview - Nanogate | 07/12/2018

Nanogate is a leading global specialist for design-oriented, high-tech surfaces and components of very high optical quality. It enhances its products with…

Back to the black
Tonkens Agrar | 07/12/2018

Improved farmgate milk prices and higher volume sales of processed vegetables enabled Tonkens to achieve its stated goal of reporting a net profit after…

Executive Interview - Finlab
Executive Interview - Finlab | 06/12/2018

In this interview, Stefan Schütze (CEO) discusses Finlab’s hybrid business profile based on its strong positioning in the Fintech landscape,…

Executive Interview - German Startup Group
Executive Interview - German Startup Group | 06/12/2018

In the interview, Christoph Gerlinger (CEO of German Startups Group), explains the company’s reshaped strategy. He describes the development of new…

Executive Interview - Noratis
Executive Interview - Noratis | 06/12/2018

Noratis is a specialised asset developer, acquiring residential rental income-producing assets with optimisation potential in non-core German cities. Investing…